Global Image-Guided Surgery Market Size to Reach USD 16.24 Billion in 2032 | Emergen Research
Increasing number of cancer radiotherapy initiatives is a major factor driving Image-Guided Surgery Market revenue growth
Vancouver, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The global image-guided surgery market size is expected to reach USD 16.24 Billion in 2032 and register a revenue CAGR of 8.4% during the forecast period, according to the latest analysis by Emergen Research. Increasing number of cancer radiotherapy initiatives is one of the major factors driving the market revenue growth. High radiation doses can be delivered to tumors utilizing sophisticated high-resolution real-time Image-Guided Radiotherapy (IGRT) employing X-rays, magnetic resonance imaging, computer tomography, or ultrasound without harming healthy organs. IGRT has been radiation oncology's most resounding success story over the past few decades, and it continues to be a major innovation driver, using real-time imaging biomarkers for customized dose administration, for instance, to advance personalized oncology.
Lack of skilled healthcare professionals is a factor expected to restrain market revenue growth. Systems for image-guided surgery must be operated by individuals who have specialized knowledge and skills. Their widespread implementation can be hampered by lack of healthcare personnel with necessary training. Real-time imaging data interpretation and integration into surgical processes are demanding tasks that need qualified individuals. The market is constrained by a shortage of educated experts, which restricts the use of image-guided surgical systems in healthcare institutions and impedes revenue growth of the market.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2133
Scope of Research
Report Details | Outcome |
Market size in 2022 | USD 7.20 Billion |
CAGR (2023-2032) | 8.4% |
Revenue forecast to 2032 | USD 16.24 Billion |
Base year for estimation | 2022 |
Historical data | 2019-2021 |
Forecast period | 2023-2032 |
Quantitative units | Revenue in USD Billion and CAGR in % from 2023 to 2032 |
Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends. |
Segments covered | Product, application, end-use, region |
Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope | U.S., Canada, Mexico, Germany, U.K., France, Spain, BENELUX, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, Israel, Rest of MEA |
Key companies profiled | Medtronic, Siemens Healthcare GmbH, Olympus Corporation, Koninklijke Philips N.V., KARL STORZ, Brainlab AG, Analogic Corporation, GE HealthCare, Stryker, Varian Medical Systems, Inc. |
Customization scope | 10 hours of free customization and expert consultation |
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2133
Major Companies and Competitive Landscape
The global image-guided surgery market is fragmented, with several large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective image-guided surgery services. Some major players included in the global image-guided surgery market report are:
Medtronic
Siemens Healthcare GmbH
Olympus Corporation
Koninklijke Philips N.V.
KARL STORZ
Brainlab AG
Analogic Corporation
GE HealthCare
Stryker
Varian Medical Systems, Inc.
Strategic Development
On 04 February 2021, upon receiving approval from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), respectively, Curadel Surgical Innovations Inc., a privately owned business that specializes in the manufacture of near-infrared fluorescent contrast agents for image-guided surgery, declared a worldwide distribution agreement with a tier one medical technology company to distribute ZW800-1.
On 18 January 2021, through its Image-Guided Therapy Mobile C-arm System - Zenition, which delivers improved clinical accuracy and efficiency to improve the outcomes for patients receiving endovascular treatment, Royal Philips, a global leader in health technology, announced that physicians will now have the benefit of advanced new 3D image guidance features.
Some Key Highlights from the Report
On 04 February 2021, Curadel Surgical Innovations Inc., a privately held company that specializes in production of near-infrared fluorescent contrast agents for image-guided surgery, announced a worldwide distribution agreement with a tier-one medical technology company to distribute ZW800-1 after receiving approval from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), respectively.
The image-guided surgery devices segment is expected to account for a significantly large revenue share during the forecast period. One major factor is the rising prevalence of intricate, minimally invasive surgical procedures, which call for higher standards of precision and accuracy. The aging population is another reason that is increasing the expense of treating diseases such as cancer and arthritis. In addition, image-guided surgical equipment is becoming more widely available and efficient as a result of technological advancements such as enhanced imaging capabilities and robots.
The cardiac surgery segment is expected to account for a significantly large revenue share during the forecast period. With the use of real-time imaging and navigational aids provided by image-guided surgical instruments, surgeons can more precisely investigate the heart's architecture, identify blockages, and perform treatments. Given the increasing need for less invasive cardiac operations and prevalence of cardiovascular diseases, the usage of image-guided surgical systems in cardiac surgery segment is driving revenue growth of this segment.
Market in North America is expected to account for largest revenue share during the forecast period as more image-guided operations are performed and leading market players and government agencies collaborate. Tens of thousands of Image-Guided Therapy (IGT) procedures are performed each year in Canada to address ailments ranging from cancer to heart disease, hence, driving market revenue growth in this region.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2133
Segments Covered in Report
For the purpose of this report, Emergen Research has segmented the global image-guided surgery market on the basis of product, application, end-use, and region:
Product Outlook (Revenue, USD Billion; 2019–2032)
Image Guided Surgery Devices
Computed Tomography (CT) Scanners
Ultrasound Systems
Magnetic Resonance Imaging (MRI)
Endoscopes
X-ray Fluoroscopy Devices
Positron Emission Tomography (PET) Devices
Single Photon Emission Computed Tomography (SPECT) Devices
Image Guided Surgery Software
Application Outlook (Revenue, USD Billion; 2019–2032)
Cardiac Surgery
Neurosurgery
Orthopedic Surgery
Urology
Oncology Surgery
Gastroenterology
Others
End-Use Outlook (Revenue, USD Billion; 2019–2032)
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Research & Academic Institutions
Regional Outlook (Revenue, USD Billion, 2019–2032)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
BENELUX
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
Israel
Rest of MEA
Browse Full Report Description + Research Methodology + Table of Content + Infographics@
https://www.emergenresearch.com/industry-report/image-guided-surgery-market
Curated Reports You Shouldn't Miss: Dive In Now!
Sinus Irrigation Systems Market, By Type (Manual Sinus Irrigation Systems, Neti Pots, Squeeze Bottles, Bulb Syringes, Electric Sinus Irrigation Systems, Battery Powered Sinus Irrigation Systems), By End-use, and By Region Forecast to 2032
Intrathecal Baclofen (ITB) Therapy Systems Market, By Product Type (Implantable Pumps, External Pumps, and Others), By Application (Spinal Cord Injury, Multiple Sclerosis, and Others), and By Region Forecast to 2032
Flexible Batteries for Wearable Medical Devices Market, By Application (Health Monitoring, Drug Delivery, and Others), By Device Type (Wearable Health Watches/Fitness Trackers, Blood Pressure Monitors, and Others), By Region Forecast to 2032
Blood Warmer Devices Market, By Sample Type (Blood Samples and Other Samples), By End-Use (Hospitals, Blood Banks & Transfusion Centers, and Tissue Banks), and By Region Forecast to 2032
Surgical Ablation Market, By Technology (Radiofrequency Ablation, Light/laser, Electrical, Cyroablation, Microwave, Ultrasound, and Hydromechanical Ablation, By Application, By End-use, and By Region Forecast to 2032
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights
Explore Our Japanese Version: Image-Guided Surgery Market
Read our Press Release @ https://www.emergenresearch.com/press-release/global-image-guided-surgery-market
